Guru Ownership Trend
Guru Analysis for Dianthus Therapeutics, Inc. (DNTH)
Dianthus Therapeutics, Inc. (DNTH), a key player in the Healthcare sector, continues to attract institutional attention.
As of Q2 2026, a total of 4 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $5.31 M.
Top institutional holders include Paul Tudor Jones and Ken Fisher.
Institutional sentiment is currently Bearish. This is evidenced by a $68.6 M net outflow during the quarter.
Recent activity highlights Paul Tudor Jones who opened a new position. Conversely, Jefferies Group reduced exposure by 97.1%.
Key Holders
Top 5 by Value
Top 5 by Conviction
Recent Activity Breakdown (Q2 2026)
Guru Consensus (Q2 2026)
FAQs for Dianthus Therapeutics, Inc. (DNTH)
Major holders include Paul Tudor Jones ($3.64 M), Ken Fisher ($2.28 M), Jefferies Group ($573,767). According to the latest reported data, 4 tracked investment managers collectively hold approximately 69,521 shares.
According to the latest 13F reporting period, sentiment appears Bearish (Net Selling). There was a net outflow of $68.6 M, with 2 managers increasing positions and 3 managers reducing holdings.
During the most recent reporting period, 2 managers trimmed their positions, while 1 fully exited DNTH. The total reported sell value was $73.28 M.
Yes, 1 managers opened new positions in DNTH, and 1 increased their existing holdings. The total reported buy value was $4.68 M.